Showing results (361-370 of 417) with videos related to

Sort By:
Pageof 42
European Journal of Haematology|July 10, 2024
CRP and sCD25 help distinguish between adult-onset Still's disease and HLHMadelaine Beckett, Caroline Spaner, Mariam Goubran, et al.
The Journal of Chemical Physics|February 4, 2012
Experimental verification of strong rotational dependence of fluorescence and predissociation yield in the b1Πu(v = 1) level of 14N2C Y Robert Wu, D L Judge, M-H Tsai, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|August 16, 2023
Rivaroxaban Versus Low-Molecular-Weight Heparins in a Broad Cohort of Patients With Cancer-Associated Venous Thromboembolism: An Analysis of the OSCAR-US ProgramKimberly Snow Caroti, Alok A Khorana, Cecilia Becattini, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|July 12, 2023
Rivaroxaban versus Apixaban for Treatment of Cancer-Associated Venous Thromboembolism in Patients at Lower Risk of BleedingKimberly Snow Caroti, Cecilia Becattini, Marc Carrier, et al.
Nature Biotechnology|January 3, 2024
Inferring super-resolution tissue architecture by integrating spatial transcriptomics with histologyDaiwei Zhang, Amelia Schroeder, Hanying Yan, et al.
The Korean Journal of Internal Medicine|March 13, 2001
A case of primary intestinal T-cell lymphoma involving entire gastrointestinal tract: esophagus to rectumM J Ahn, Y W Park, D Han, et al.
The American Journal of Medicine|February 25, 2014
Venous thromboembolism in older adults: A community-based studyFrederick A Spencer, Jerry H Gurwitz, Sam Schulman, et al.
Thrombosis and Haemostasis|February 1, 2024
Comparison of Clinical Outcomes in Patients with Active Cancer Receiving Rivaroxaban or Low-Molecular-Weight Heparin: The OSCAR-UK StudyAlexander T Cohen, Christopher Wallenhorst, Marcella Rivera, et al.
Thrombosis and Haemostasis|September 19, 2024
Risk of Recurrent Venous Thromboembolism in Patients with Cancer: An Individual Patient Data Meta-analysis and Development of a Prediction ModelVincent R Lanting, Toshihiko Takada, Floris T M Bosch, et al.
JACC. Cardiooncology|May 5, 2023
Effectiveness and Safety of Rivaroxaban and Low Molecular Weight Heparin in Cancer-Associated Venous ThromboembolismCraig I Coleman, Kimberly Snow Caroti, Khaled Abdelgawwad, et al.
Pageof 42